A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation

Armin Rashidi, Eric J. Huselton, Heather E. Stefanski, Todd E. DeFor, Ryan Shanley, Jaebok Choi, John F. DiPersio, Mark Juckett, Jeffrey S. Miller, Daniel J. Weisdorf, Mark A. Schroeder

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences